U.S. flag

An official website of the United States government

NM_000155.4(GALT):c.292G>C (p.Asp98His) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Dec 11, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000790788.14

Allele description [Variation Report for NM_000155.4(GALT):c.292G>C (p.Asp98His)]

NM_000155.4(GALT):c.292G>C (p.Asp98His)

Gene:
GALT:galactose-1-phosphate uridylyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9p13.3
Genomic location:
Preferred name:
NM_000155.4(GALT):c.292G>C (p.Asp98His)
HGVS:
  • NC_000009.12:g.34647531G>C
  • NG_009029.2:g.5943G>C
  • NG_028966.1:g.347G>C
  • NM_000155.4:c.292G>CMANE SELECT
  • NM_001258332.2:c.50+273G>C
  • NP_000146.2:p.Asp98His
  • NP_000146.2:p.Asp98His
  • NC_000009.11:g.34647528G>C
  • NM_000155.2:c.292G>C
  • NM_000155.3:c.292G>C
Links:
dbSNP: rs111033670
NCBI 1000 Genomes Browser:
rs111033670
Molecular consequence:
  • NM_001258332.2:c.50+273G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000155.4:c.292G>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
6

Condition(s)

Synonyms:
none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000330952Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions)
Pathogenic
(Nov 25, 2015)
germlineclinical testing

Citation Link,

SCV005413870Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Dec 11, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown6not providednot providednot providednot providedclinical testing

Citations

PubMed

The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency.

Berry GT, Moate PJ, Reynolds RA, Yager CT, Ning C, Boston RC, Segal S.

Mol Genet Metab. 2004 Jan;81(1):22-30.

PubMed [citation]
PMID:
14728988

Analysis of galactosemia-linked mutations of GALT enzyme using a computational biology approach.

Facchiano A, Marabotti A.

Protein Eng Des Sel. 2010 Feb;23(2):103-13. doi: 10.1093/protein/gzp076. Epub 2009 Dec 11.

PubMed [citation]
PMID:
20008339
See all PubMed Citations (5)

Details of each submission

From Eurofins Ntd Llc (ga), SCV000330952.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided4not providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV005413870.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (5)

Description

PP3, PM2_moderate, PM3, PM5, PS3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided2not providednot providednot provided

Last Updated: May 3, 2025